Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02GNN
|
||||
Former ID |
DNC010214
|
||||
Drug Name |
N-methyl-3,3-diphenylpropan-1-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530331] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H19N
|
||||
Canonical SMILES |
CNCCC(C1=CC=CC=C1)C2=CC=CC=C2
|
||||
InChI |
1S/C16H19N/c1-17-13-12-16(14-8-4-2-5-9-14)15-10-6-3-7-11-15/h2-11,16-17H,12-13H2,1H3
|
||||
InChIKey |
AKEGHAUFMKCWGX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [530331] | |
Histamine H1 receptor | Target Info | Inhibitor | [530331] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP58:Monoamine GPCRs | |||||
IL-4 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.